Investors

Date	Name	Title	Type	Shares Traded	Price Range
Jan 5, 2010	goldberg murray a	Officer	Automatic Sell	22,611	24.86
Jan 5, 2010	goldberg murray a	Officer	Option Execute	36,980	9.49 - 13.00
Dec 15, 2008	goldberg murray a	Officer	Option Execute	1,700	7.41
Jan 2, 2009	goldberg murray a	Officer	Option Execute	1,300	7.41
Dec 8, 2008	goldberg murray a	Officer	Disposition (Non Open Market)	120	n/a
Dec 17, 2007	goldberg murray a	Officer	Disposition (Non Open Market)	200	n/a
Sep 19, 2008	kolinski stuart	Officer	Sell	9,992	23.40 - 23.69
Sep 19, 2008	kolinski stuart	Officer	Option Execute	9,992	8.50
Feb 2, 2010	kolinski stuart	Officer	Automatic Sell	6,913	27.16
Feb 2, 2010	kolinski stuart	Officer	Option Execute	12,314	8.50
Jan 27, 2010	kolinski stuart	Officer	Automatic Sell	4,359	27.00
Jan 27, 2010	kolinski stuart	Officer	Option Execute	4,359	8.50
Feb 3, 2010	kolinski stuart	Officer	Automatic Sell	5,401	27.66 - 28.08
Jun 3, 2010	kolinski stuart	Officer	Automatic Sell	6,784	30.02
Jun 3, 2010	kolinski stuart	Officer	Option Execute	12,500	8.50
Sep 1, 2011	larosa joseph j	Officer	Acquisition (Non Open Market)	10,000	n/a
Mar 9, 2011	mccorkle douglas s	Officer	Automatic Sell	9,400	40.00
Mar 9, 2011	mccorkle douglas s	Officer	Option Execute	9,400	20.32
Mar 21, 2011	mccorkle douglas s	Officer	Automatic Sell	10,600	40.02
Mar 21, 2011	mccorkle douglas s	Officer	Option Execute	10,600	20.32
Showing 341-360 of 627 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.